Invention Grant
US08822511B2 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
有权
1,2,5-恶二唑作为吲哚胺2,3-双加氧酶的抑制剂
- Patent Title: 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
- Patent Title (中): 1,2,5-恶二唑作为吲哚胺2,3-双加氧酶的抑制剂
-
Application No.: US14033117Application Date: 2013-09-20
-
Publication No.: US08822511B2Publication Date: 2014-09-02
- Inventor: Andrew P. Combs , Eddy W. Yue , Richard B. Sparks , Wenyu Zhu
- Applicant: Incyte Corporation
- Applicant Address: US DE Wilmington
- Assignee: Incyte Corporation
- Current Assignee: Incyte Corporation
- Current Assignee Address: US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: A61K31/4245
- IPC: A61K31/4245 ; C07D413/12 ; C07D271/08
Abstract:
The present invention is directed to 1,2,5-oxadiazole derivatives, and compositions of the same, which are inhibitors of indoleamine 2,3-dioxygenase and are useful in the treatment of cancer and other disorders, and to the processes and intermediates for making such 1,2,5-oxadiazole derivatives.
Public/Granted literature
- US20140023663A1 1,2,5-Oxadiazoles As Inhibitors Of Indoleamine 2,3-Dioxygenase Public/Granted day:2014-01-23
Information query
